Disc Medicine Is A Clinical Stage Biopharmaceutical Company Based In Watertownmassachusettsfocused On Developing Innovative Therapies For Hematologic Disordersfounded In 2017The Company Aims To Transform The Lives Of Patients Suffering From Serious Blood Related Diseases By Emphasizing Red Blood Cell Biologyheme Biosynthesisand Iron Homeostasis The Company Is Advancing Several Promising Therapiesincluding Bitopertin For Erythropoietic Porphyrias And Diamond Blackfan Anemiadisc 0974A Monoclonal Antibody For Anemia Related To Myelofibrosis And Chronic Kidney Diseaseand Disc 3405Which Targets Polycythemia Veradisc Medicine Is Led By A Team Of Experienced Professionalsincluding Ceo John Quiseland Is Committed To Scientific Rigor And Compassion In Its Mission To Improve Patient Outcomes
